Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery

Samsung Medical Center

Status: Unknown

Conditions: Dry Eye

Treatments: Drug: Omega 3

Study type: Interventional

Funder types: Other

Identifiers

NCT04411615

2020-01-150

Details and patient eligibility

About

To evaluate the clinical outcomes of the systemic re-esterified triglyceride (rTG) form of omega-3 fatty acids in patients with dry eye symptoms after cataract surgery

Enrollment: 30 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Non complicated cataract surgery
• Patients with dry eye symptom

Exclusion criteria

• Using steroid eyedops,
• Using antibiotics eyedrops
• Surgery other than Cataract surgery
• Contact lens wearer
• Other systemic disease

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Omega

Experimental group

Description:

Omega-3 re-esterified triglyceride form

Treatment:

Drug: Omega 3